Free Trial

Curaleaf (OTCMKTS:CURLF) Trading Up 8.3% - Here's Why

Curaleaf logo with Medical background

Key Points

  • Shares of Curaleaf Holdings, Inc. rose by 8.3% to $2.88 after previously closing at $2.66, with trading volume increasing by 25%.
  • Cormark upgraded Curaleaf from a "hold" to a "moderate buy" rating, indicating positive sentiment from analysts.
  • Curaleaf reported a quarterly earnings per share of ($0.06), exceeding expectations and anticipates posting a -0.25 EPS for the current fiscal year.
  • MarketBeat previews the top five stocks to own by October 1st.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) shares shot up 8.3% on Monday . The stock traded as high as $2.90 and last traded at $2.88. 963,991 shares were traded during trading, an increase of 25% from the average session volume of 774,088 shares. The stock had previously closed at $2.66.

Analysts Set New Price Targets

Separately, Cormark upgraded shares of Curaleaf from a "hold" rating to a "moderate buy" rating in a research note on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, According to MarketBeat, Curaleaf presently has a consensus rating of "Strong Buy".

Get Our Latest Analysis on Curaleaf

Curaleaf Stock Down 1.4%

The company has a quick ratio of 0.70, a current ratio of 1.47 and a debt-to-equity ratio of 1.00. The stock has a market capitalization of $1.89 billion, a PE ratio of -8.81 and a beta of 0.69. The firm's fifty day moving average is $1.46 and its 200-day moving average is $1.16.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. On average, equities research analysts predict that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Articles

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.